Present status of adjuvant chemotherapy for elderly breast cancer patients.
Elderly breast cancer patients are underrepresented in clinical trials, leading to a lack of knowledge regarding their tolerance of modern chemotherapy regimens. In addition, physicians are often reluctant to treat older patients with chemotherapy due to potential side effects. This article summarizes the up-to-date literature on chemotherapy in elderly patients with breast cancer, evaluates the impact of the patients' comorbidities and treatment alterations and aims to encourage treating patients adequately according to their disease in combination with the biological age rather than the chronological age alone. Finally, a short overview is given of the recruiting studies in Europe evaluating chemotherapy in elderly patients.
German Breast Group, Neu-Isenburg, Germany ; Städtische Kliniken Offenbach, Germany.
Sibylle
S
Loibl
German Breast Group, Neu-Isenburg, Germany ; Frauenklinik, Bürgerhospital Frankfurt/M., Germany.
Mattea
M
Reinisch
Adjuvant chemotherapy; Breast cancer; Elderly patients